0001062993-22-011805.txt : 20220506 0001062993-22-011805.hdr.sgml : 20220506 20220506165521 ACCESSION NUMBER: 0001062993-22-011805 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20220623 FILED AS OF DATE: 20220506 DATE AS OF CHANGE: 20220506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FSD Pharma Inc. CENTRAL INDEX KEY: 0001771885 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39152 FILM NUMBER: 22902085 BUSINESS ADDRESS: STREET 1: FIRST CANADIAN PLACE STREET 2: 100 KING STREET WEST, SUITE 4000 CITY: TORONTO STATE: A6 ZIP: M5X 1A4 BUSINESS PHONE: (416) 854-8884 MAIL ADDRESS: STREET 1: FIRST CANADIAN PLACE STREET 2: 100 KING STREET WEST, SUITE 4000 CITY: TORONTO STATE: A6 ZIP: M5X 1A4 6-K 1 form6k.htm FORM 6-K FSD Pharma Inc.: Form 6-K - Filed by newsfilecorp.com

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of: May 2022

Commission File Number: 001-39152

FSD PHARMA INC.
(Translation of registrant's name into English)


199 Bay St., Suite 4000

Toronto, Ontario M5L 1A9, Canada
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

FSD Pharma Inc.

(Registrant)

     
Date:  May 6, 2022 By: /s/ Nathan Coyle
    Nathan Coyle, Chief Financial Officer


EXHIBIT INDEX

Exhibit Description
   
99.1 Notice of Record and Meeting Date


EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 FSD Pharma Inc.: Exhibit 99.1 - Filed by newsfilecorp.com

MAY 3, 2022

TO ALL APPLICABLE EXCHANGES AND COMMISSIONS:

RE: FSD PHARMA INC.
Confirmation of Notice of Record and Meeting Dates
 

We are pleased to confirm that Notice of Record and Meeting Date was sent to The Canadian Depository for Securities. We advise the following with respect to the upcoming Annual General Meeting of Security Holders for the subject issuer:

1 ISIN: CLASS B SUBORDINATE VOTING
CUSIP: CLASS B SUBORDINATE VOTING
CA35954B2066
35954B206
     
  ISIN: CLASS A MULTIPLE VOTING SHARES
CUSIP: CLASS A MULTIPLE VOTING SHARES
CARFYQMV2181
RFYQMV218
     
2 Date Fixed for the Meeting: June 23, 2022
     
3 Record Date for Notice: May 19, 2022
     
4 Record Date for Voting: May 19, 2022
     
5 Beneficial Ownership Determination Date: May 19, 2022
     
6 Classes or Series of Securities that entitle the holder to receive Notice of the Meeting: CLASS B SUBORDINATE VOTING SHARES
CLASS A MULTIPLE VOTING SHARES
     
7 Classes or Series of Securities that entitle the holder to vote at the meeting: CLASS B SUBORDINATE VOTING SHARES
CLASS A MULTIPLE VOTING SHARES
     
8 Business to be conducted at the meeting: Annual General
     
9 Notice-and-Access: NO
     
10 Reporting issuer is sending proxy-related materials directly to Non-Objecting Beneficial Owners: NO
     
11 Issuer paying for delivery to Objecting Beneficial Owners: YES


With kindest regards,

"Lisa Cripps"

Marrelli Trust Company Limited

Lisa Cripps

President

lcripps@marrellitrust.ca


GRAPHIC 3 exhibit99-1x001.jpg GRAPHIC begin 644 exhibit99-1x001.jpg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